Cardiovascular

Micro Medical completes enrollment for stent pivotal trial

Micro Medical has completed enrolment for a US pivotal clinical study evaluating the safety and effectiveness of its MicroStent system…

Bioxodes enrols first patient in Phase IIa ischemic stroke trial

Belgium-based Bioxodes has enrolled the first patient in its Phase IIa study investigating a pipeline candidate Ir-CPI for ischemic stroke.…

AstraZeneca to halt Phase III hyperkalaemia trials of Lokelma

AstraZeneca has announced plans for the discontinuation of two Phase III clinical trials of Lokelma (sodium zirconium cyclosilicate) being analysed…

BiVACOR wins IDE to start first-in-human study for artificial heart

The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to BiVACOR’s total artificial heart (BTAH),…

Pipeline Moves: Approval prospects drop for Bayer’s cardiovascular drug after Phase III termination

This week on Pipeline Moves, we kick off by looking at Phase III trial terminations by Bayer and Johnson &…

Post hoc analysis of SCORED trial sheds positive light on Inpefa for heart failure

At this year’s American Heart Association Scientific Session, positive results were presented from Lexicon Pharmaceuticals’s SCORED analysis of Inpefa (sotagliflozin),…

Surmodics reveals two-year data from drug-coated balloon trial

Surmodics’s drug-coated balloon met primary safety and efficacy endpoints in a first-in-human study for the treatment of occlusive disease of…

Pipeline Moves: Prospects drop after Phase III ovarian cancer trial failure

This week on Pipeline Moves, we kickoff by looking at two Phase III trials in oncology and kidney disease that…

Acorai wins €2.3m grant to help fund trial for heart monitoring device

Cardiology start-up Acorai has secured a €2.3m ($2.46m) grant with a follow-on €10m ($10.70m) investment from the European Innovation Council…

ResoTher Pharma given grant for myocardial infarction drug trial

The European Innovation Council (EIC) has given €2.5m ($2.67m) to Danish biopharmaceutical company ResoTher Pharma to advance the development of its lead…

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Vist our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close